Multi-target colorectal cancer screening test for the detection of colorectal advanced adenomatous polyps and cancer (DeeP-CQuality indicatorsUS Food and Drug AdministrationStool DNA testing is an emergent noninvasive colorectal cancer (CRC) screening approach with attractive biological and clinical features...
The noninvasive test provides a beneficial screening tool for patients 45 and older at average risk for colorectal cancer.
Blasi, MPH JAMA Original Investigation Multitarget Stool RNA Test for Colorectal Cancer Screening Erica K. Barnell, MD, PhD; Elizabeth M. Wurtzler, PhD; Julie La Rocca, MS; Thomas Fitzgerald, MS; Jessica Petrone, MD; Yansheng Hao, MD, PhD; Yiming Kang, PhD; Faith L. Holmes, MD...
The Stool DNA Test: An Emerging Technology in Colorectal Cancer ScreeningGreenwald, Beverly PhD, RN, CNS, CGRN Abstract The stool DNA test is considered an emerging technology in screening for colorectal cancer. The stool DNA test detects DNA markers which are shed from cells of ...
Cancer Prev Res (Phila). 2020;13(5):443-448. doi:10.1158/1940-6207.CAPR-19-0527PubMedGoogle ScholarCrossref 26. Imperiale TF, Kisiel JB, Itzkowitz SH, et al. Specificity of the multi-target stool DNA test for colorectal cancer screening in average-risk 45–49 year-...
lance continued until the diagnosis of colorectal cancer or death. For the base-case analysis, we assumed persons were 100% adherent to the screening test of interest and with the recommended follow-up and surveillance; al-
Importance of advanced adenomas as endpoints for colorectal cancer screening programs The identification and removal of AAs, the precursor lesions of CRC, is a key strategy for reducing both the mortality and the burden of this disease. Yet, CRC remains a significant public health threat. Despite ...
31 studies with a total of 120,255 participants. Each individual had a FIT (short for fecal immunochemical test), which identifies hidden blood in stool. FIT results were compared to the finding of a subsequentscreening colonoscopyand were found to have high detection rates for colorectal cancer...
Colorectal cancer is the most common fatal malignancy among non-smokers in North America and Europe. Better tools are needed to improve the accuracy, compliance rates, safety, and affordability of screening. Stool testing has several important advantages over structural screening methods and warrants mo...
Ultimately, however, the best test for CRC screening is the one performed stool-based CRC screening as an initial or alternative option can increase participation in CRC screening. 展开 关键词: Advanced adenoma Colorectal cancer Fit Screening gFOBT hsFOBT mtsDNA ...